CARMA: Campylobacter Risk Management and Assessment

26-3-03


Click here to start


Table of Contents

CARMA: Campylobacter Risk Management and Assessment

Campylobacter jejuni

CARMA is a collaboration between ...

Goals of the CARMA project

Information to support decision making

Risk profile: major conclusions

Incidence of Campylobacter associated illness (per year, population 16 million)

Trend in laboratory reported cases of human campylobacteriosis

Age distribution

Seasonal variation

Sources of Campylobacter

Prevalence of Campylobacter in broilers

Prevalence of Campylobacter in poultry products (retail)

Risk modelling

MPRM kipfilet schema

General approach of CARMA (1)

General approach of CARMA (2)

Interventions to be evaluated

Cost-effectiveness analysis

Costs of campylobacteriosis in the Netherlands (global estimate, Bunte et al., 2001)

DALYs as unit measures for disease burden

Disease burden of infection with thermophilic Campylobacter spp. in the Netherlands

Possible outcomes

Cost - effectiveness of preventing gastro-enteritis: a hypothetical example

Conclusion

Author: Arie Havelaar